Induction of premature menstruation with anabolic steroids.
D000328:Adult; D045930:Anabolic Agents / Q000494:pharmacology*; D005032:Ethylestrenol / Q000494:pharmacology; D005260:Female; D005474:Fluoxymesterone / Q000494:pharmacology; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008598:Menstruation / Q000187:drug effects*; D008696:Methandrostenolone / Q000494:pharmacology; D009277:Nandrolone / Q000494:pharmacology*; D010060:Ovulation / Q000187:drug effects; D010074:Oxandrolone / Q000494:pharmacology; D010110:Oxymetholone / Q000494:pharmacology*; D011374:Progesterone / Q000097:blood; D013197:Stanozolol / Q000494:pharmacology; D013997:Time Factors
D045930:Anabolic Agents; D011374:Progesterone; D013197:Stanozolol; D009277:Nandrolone; D010074:Oxandrolone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D005474:Fluoxymesterone; D005032:Ethylestrenol; D008696:Methandrostenolone; D010110:Oxymetholone